-
Posted by
Two Blokes May 23 -
Filed in
Stock
-
4 views
German drugmaker Bayer on Friday won an endorsement by the European Medicines Agency to extend the intervals between shots of its anti-blindness treatment Eylea, giving it a potential edge over Roche's rival treatment Vabysmo.
